Gregory P Takacs,
GRADUATE RES AST
Department:
MD-PHARMACOLOGY / THERAPEUTICS
Business Phone:
(352) 294-5351
Business Email:
gtakacs@ufl.edu
Publications
2023
Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
bioRxiv : the preprint server for biology.
[DOI] 10.1101/2023.05.15.540846.
[PMID] 37292799.
2023
Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
Journal of mathematical biology.
88(1)
[DOI] 10.1007/s00285-023-02027-y.
[PMID] 38099947.
2022
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner.
Frontiers in immunology.
13
[DOI] 10.3389/fimmu.2022.993444.
[PMID] 36685592.
2021
Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.
Pharmacology & therapeutics.
222
[DOI] 10.1016/j.pharmthera.2020.107790.
[PMID] 33316289.
2020
Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia.
Cancers.
12(12)
[DOI] 10.3390/cancers12123710.
[PMID] 33321907.
Contact Details
Phones:
- Business:
- (352) 294-5351
Emails:
- Business:
- gtakacs@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100267
GAINESVILLE FL 32610 - Business Street:
-
ARB 5-234
1200 Newell Drive
GAINESVILLE FL 32610